Serum cortisol concentration in patients with major depression after treatment with clomipramine.
Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 4
Abstract
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and elevated cortisol (CORT) levels are characteristics of the pathophysiology of major depressive disorder. The aim of this study was to determine whether increased plasma CORT levels appear in patients with major depression and if effective antidepressant treatment by clomipramine (CLO) leads to regulation of CORT level. Plasma CORT levels were measured using high performance liquid chromatography (HPLC) methods in patients with major depression at time zero (before therapy) and after 3 h, 24 h, 4, 6 and 8 weeks of CLO administration. The study included 17 patients (12 women, 5 men; mean age 54.5 years, SD =12.3) and 21 healthy comparison subjects. The patients had a mean score on the 21-item Hamilton Depression Rating Scale (HDRS) of 26.8 (range 22-35). Eight of the patients with major depression recruited for the study showed a 46% increase in CORT concentration compared to the established standard. In 13 patients treated with CLO, serum CLO levels reached a therapeutic range. In recovered depressed patients, antidepressant treatment significantly reduced HDRS scores from the 6th week of treatment. A drop in plasma CORT levels in recovered depressed subjects occurred 0 to 6 weeks after CLO treatment (n = 5, p < 0.046). However, neither subject group exhibited any definitive markers of CORT secretion. In the population studied, patients had distinct profiles of HPA axis dysregulation. Finding a linear correlation between lower CORT secretion and therapeutic plasma CLO levels is the first aim of monitored therapy and may be important for understanding the pathophysiology of major depressive disorder.
Authors and Affiliations
Jadwiga Piwowarska, Małgorzata Wrzosek, Maria Radziwoń-Zaleska, Beata Ryszewska-Pokraśniewicz, Michał Skalski, Halina Matsumoto, Agata Biernacka-Bazyluk, Waldemar Szelenberger, Jan Pachecka
Keywords
Related Articles
- EP ID EP149865
- DOI -
- Views 64
- Downloads 0
GABA(B) receptors in drug addiction.
Preclinical studies and clinical trials carried out within the past few years have provided a premise that gamma-aminobutyric acid (GABA) transmission and GABA(B) receptors play a modulatory role in the mechanism of acti...
Taurine modulates calcium influx under normal and ototoxic conditions in isolated cochlear spiral ganglion neurons.
The effect of taurine on calcium homeostasis of isolated cochlear spiral ganglion neurons under normal and ototoxic conditions was investigated using fluo-3 calcium imaging. Sole application of taurine (15 mM) induced an...
Methotrexate in rheumatoid arthritis.
Avariety of disease-modifying antirheumatic drugs (DMARDs) are available to control the clinical activity of rheumatoid arthritis (RA). Methotrexate (MTX), an analogue of folic acid and of aminopterin, is the most common...
Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties.
Humanin (HN) is a newly discovered 24-amino acid peptide, which may suppress neuronal cell death. HN cDNA includes an open reading frame (HN-ORF) of 75 bases located 950 bases downstream of the 5' end of the HN cDNA. It...
Concomitant use of carbamazepine and olanzapine and the effect on some behavioral functions in rats.
As shown in clinical studies, combinations of first generation normothymics (carbamazepine - CBZ) with atypical neuroleptics (olanzapine - OLA) lead to improvements in approximately half of patients treated for relapses...